Annual FCF
-$40.65 M
-$6.31 M-18.38%
31 December 2023
Summary:
Compass Therapeutics annual free cash flow is currently -$40.65 million, with the most recent change of -$6.31 million (-18.38%) on 31 December 2023. During the last 3 years, it has fallen by -$13.74 million (-51.06%). CMPX annual FCF is now -91.43% below its all-time high of -$21.23 million, reached on 31 December 2021.CMPX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$11.10 M
-$341.00 K-3.17%
01 September 2024
Summary:
Compass Therapeutics quarterly free cash flow is currently -$11.10 million, with the most recent change of -$341.00 thousand (-3.17%) on 01 September 2024. Over the past year, it has dropped by -$5.16 million (-87.04%). CMPX quarterly FCF is now -190.14% below its all-time high of -$3.82 million, reached on 01 September 2021.CMPX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$48.10 M
-$5.16 M-12.02%
01 September 2024
Summary:
Compass Therapeutics TTM free cash flow is currently -$48.10 million, with the most recent change of -$5.16 million (-12.02%) on 01 September 2024. Over the past year, it has dropped by -$9.12 million (-23.40%). CMPX TTM FCF is now -518.81% below its all-time high of -$7.77 million, reached on 01 March 2020.CMPX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | -87.0% | -23.4% |
| 3 y3 years | -51.1% | -190.1% | -114.3% |
| 5 y5 years | -13.9% | - | - |
CMPX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -91.4% | at low | -190.1% | +20.1% | -126.5% | at low |
| 5 y | 5 years | -91.4% | at low | -190.1% | +20.1% | -518.8% | at low |
| alltime | all time | -91.4% | at low | -190.1% | +20.1% | -518.8% | at low |
Compass Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.10 M(+3.2%) | -$48.10 M(+12.0%) |
| June 2024 | - | -$10.75 M(-22.6%) | -$42.94 M(+1.5%) |
| Mar 2024 | - | -$13.89 M(+12.3%) | -$42.31 M(+4.1%) |
| Dec 2023 | -$40.65 M(+18.4%) | -$12.36 M(+108.4%) | -$40.65 M(+4.3%) |
| Sept 2023 | - | -$5.93 M(-41.4%) | -$38.98 M(-11.4%) |
| June 2023 | - | -$10.12 M(-17.2%) | -$44.02 M(+14.5%) |
| Mar 2023 | - | -$12.23 M(+14.3%) | -$38.43 M(+11.9%) |
| Dec 2022 | -$34.34 M(+61.7%) | -$10.70 M(-2.5%) | -$34.34 M(+18.1%) |
| Sept 2022 | - | -$10.97 M(+141.8%) | -$29.08 M(+32.6%) |
| June 2022 | - | -$4.54 M(-44.2%) | -$21.94 M(-7.2%) |
| Mar 2022 | - | -$8.14 M | -$23.64 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$21.23 M(-21.1%) | - | - |
| Dec 2021 | - | -$5.44 M(+42.3%) | -$21.23 M(-5.4%) |
| Sept 2021 | - | -$3.82 M(-38.7%) | -$22.45 M(-13.0%) |
| June 2021 | - | -$6.24 M(+8.8%) | -$25.80 M(+3.7%) |
| Mar 2021 | - | -$5.73 M(-13.9%) | -$24.87 M(-7.6%) |
| Dec 2020 | -$26.91 M(-16.4%) | -$6.66 M(-7.2%) | -$26.91 M(+32.9%) |
| Sept 2020 | - | -$7.18 M(+35.3%) | -$20.25 M(+54.9%) |
| June 2020 | - | -$5.30 M(-31.8%) | -$13.08 M(+68.2%) |
| Mar 2020 | - | -$7.77 M | -$7.77 M |
| Dec 2019 | -$32.21 M(-9.8%) | - | - |
| Dec 2018 | -$35.70 M | - | - |
FAQ
- What is Compass Therapeutics annual free cash flow?
- What is the all time high annual FCF for Compass Therapeutics?
- What is Compass Therapeutics annual FCF year-on-year change?
- What is Compass Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Compass Therapeutics?
- What is Compass Therapeutics quarterly FCF year-on-year change?
- What is Compass Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Compass Therapeutics?
- What is Compass Therapeutics TTM FCF year-on-year change?
What is Compass Therapeutics annual free cash flow?
The current annual FCF of CMPX is -$40.65 M
What is the all time high annual FCF for Compass Therapeutics?
Compass Therapeutics all-time high annual free cash flow is -$21.23 M
What is Compass Therapeutics annual FCF year-on-year change?
Over the past year, CMPX annual free cash flow has changed by -$6.31 M (-18.38%)
What is Compass Therapeutics quarterly free cash flow?
The current quarterly FCF of CMPX is -$11.10 M
What is the all time high quarterly FCF for Compass Therapeutics?
Compass Therapeutics all-time high quarterly free cash flow is -$3.82 M
What is Compass Therapeutics quarterly FCF year-on-year change?
Over the past year, CMPX quarterly free cash flow has changed by -$5.16 M (-87.04%)
What is Compass Therapeutics TTM free cash flow?
The current TTM FCF of CMPX is -$48.10 M
What is the all time high TTM FCF for Compass Therapeutics?
Compass Therapeutics all-time high TTM free cash flow is -$7.77 M
What is Compass Therapeutics TTM FCF year-on-year change?
Over the past year, CMPX TTM free cash flow has changed by -$9.12 M (-23.40%)